// Press Release

Common water treatments could damage DNA

Common water treatments could damage DNA Scientists are warning that a water treatment widely used in developing countries could be damaging the DNA of those drinking it. Despite poor evidence of their effectiveness as a water disinfectant, colloidal silver and silver nanoparticles are increasingly being promoted for treating potentially contaminated drinking water in low income … Continue reading Common water treatments could damage DNA

Dr. Spaner at Sunnybrook Research Institute receives prestigious UFCW Canada Award for Leukemia Research

Dr. Spaner at Sunnybrook Research Institute receives prestigious UFCW Canada Award for Leukemia Research   TORONTO, June 16, 2017 /CNW/ – The Leukemia and Lymphoma Society of Canada together with  its largest philanthropic partner, UFCW Canada (United Food and Commercial Workers Canada union), are proud to announce  that Dr. David Spaner, MD, PhD, FRCP is the … Continue reading Dr. Spaner at Sunnybrook Research Institute receives prestigious UFCW Canada Award for Leukemia Research

Experiences reflect unique DNA of Ontario travel destinations

Experiences reflect unique DNA of Ontario travel destinations Stratford, Bayfield and Elora & Fergus think outside the box to engage visitors   STRATFORD, Ont. (June 12, 2017) – Picture rappelling down a sheer rock wall to get to your table for a delicious dinner served on a beach beside a gorgeous winding river.   How … Continue reading Experiences reflect unique DNA of Ontario travel destinations

New research reveals two-thirds of Canadian women experience period leaks

A new study from Always My Fit, conducted by MSLGROUP Research that surveyed Canadian women aged 18 to 35 who rely mostly on pads for period protection (which represents 70% of survey respondents), shows that there is room for improvement when it comes to selecting the right period protection to avoid leaks. Here’s why.   … Continue reading New research reveals two-thirds of Canadian women experience period leaks

Steady stream of innovation to attract funding from diverse industries and drive growth opportunities, finds Frost & Sullivan’s TechVision team

Steady stream of innovation to attract funding from diverse industries and drive growth opportunities, finds Frost & Sullivan’s TechVision team London – 31 May, 2017 – Robotic exoskeletons are rapidly breaking out of the realm of sci-fi, finding application across varied industries, including healthcare, military, sports, robotics, construction, logistics, warehouse and industrial automation. Their exceptional … Continue reading Steady stream of innovation to attract funding from diverse industries and drive growth opportunities, finds Frost & Sullivan’s TechVision team

ProMIS Neurosciences Identifies Novel Therapeutic Epitope Target for ALS and Dementia

ProMIS Neurosciences Identifies Novel Therapeutic Epitope Target for ALS and Dementia Company files United States patent application for novel epitope target identified on misfolded forms of the protein TDP43 TSX: PMN TORONTO and CAMBRIDGE, MA, May 31, 2017 /CNW/ – ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments … Continue reading ProMIS Neurosciences Identifies Novel Therapeutic Epitope Target for ALS and Dementia

Autism Speaks Canada Announces Their Annual Fundraising Walk Comes to Toronto

Autism Speaks Canada Announces Their Annual Fundraising Walk Comes to Toronto   TORONTO, May 31, 2017 /CNW/ – Autism Speaks Canada, part of North America’s largest autism science organization, announced that Toronto’s Autism Speaks Canada Walk will take place at Nathan Phillips Square on Sunday, June 4.  Registration opens at 8:30 with the Walk taking … Continue reading Autism Speaks Canada Announces Their Annual Fundraising Walk Comes to Toronto

Pro athletes and celebrities tee off at eighth annual Joe Carter Classic Celebrity Golf Tournament

Pro athletes and celebrities tee off at eighth annual Joe Carter Classic Celebrity Golf Tournament June 14 and 15; DMC and Arrested Development to perform at VIP After-Party Star-studded charity event has raised $2.5 million  to benefit children’s charities to date TORONTO, ON – Major League Baseball legend and World Series champion Joe Carter will be … Continue reading Pro athletes and celebrities tee off at eighth annual Joe Carter Classic Celebrity Golf Tournament

THE GOOD GEISHA OPENS SHOP IN PACIFIC MALL

THE GOOD GEISHA OPENS SHOP IN PACIFIC MALL TORONTO, ON – Wednesday, May 17th, 2017 – When The Good Geisha first opened their shop last year in Kensington Market, owners Anna Chow and Amber Gotzmeister never imaged they would be opening a second location so soon before their one-year anniversary. The overwhelming demand for microblading … Continue reading THE GOOD GEISHA OPENS SHOP IN PACIFIC MALL

Buying Bread or Paying for Your Medication? Public Drug Plans Must Cover Cost of Latest Depression Medications OTTAWA, May 17, 2017 /CNW/ – Ron Campbell and Brianne Moore — on behalf of millions of other Canadians living with mental illness and depression — have a message for Minister of Health Jane Philpott following her address yesterday at The Economic Club of Canada. Their message is this: an effectively reformed system to review patented medications must include the many people who are currently shut out from getting the latest — and most effective — medications for their depression. Ron and Brianne are referring to Canada’s publicly funded drug plan system, which currently does not cover many of the latest innovative depression medications that Canadians need to treat their illness. Those medications are only available through private health plans. Right now, Canada’s most vulnerable, including veterans, seniors, single parents, Indigenous peoples, the unemployed and homeless people, are shut out. That’s because publicly funded drug plans don’t cover the cost of the latest innovative medicines designed to treat depression. All these Canadians, say Ron and Brianne, are part of an untold story. “It’s a travesty,” says Ron, a retired RCMP officer with both PTSD and major depressive disorder. He’s one of the lucky ones because he has private drug plan coverage. After years of tweaking and crashing, more tweaking and crashing, his specialist found the right combination of medications that make it possible for him to cope — and live. “I’m finally in the best place I’ve been in 13 years,” says the man who twice came within a hair’s breadth of ending his life, once with pistol in hand. “I don’t know what I would have done if I didn’t have private drug plan coverage.” Ron is concerned about all those others he sees who struggle to get through their day without the benefit of the medication that will work for them — or people like Brianne who sometimes forfeits the medication she needs when she can’t afford it. Brianne is only 19, but she has struggled with mental illness for virtually her entire life and has had to pay for her own medications for the last three years. Life’s hard, but things would certainly be easier if her medication was covered under the public drug plan. “You shouldn’t have to choose between buying food or the medication you need to stay mentally healthy,” she says. “Unfortunately, sometimes those are the only choices I have.” Ron and Brianne are members of the newly formed Canadians for Equitable Access to Depression Medications (CEADM). CEADM is calling on Minister Philpott to fix the system, ensuring that all Canadians living with mental illness, regardless of their income, have access to the latest medications for depression. “Minister Philpott is correct to tackle the high price of patented medications, and we are pleased that she has also touched on the important issue of access, but her plan for reform does not go far enough,” says Phil Upshall, a member of CEADM’s National Leadership Team and National Executive Director of the Mood Disorders Society of Canada. “Yes, developing a common national formulary that reflects the 21st century’s ‘patient-centered care’ philosophy is an important step in the right direction to improve affordability and accessibility. But Canada’s inequitable public drug plan system, which leaves many people out in the cold, the hardest hit being the most vulnerable in society and those with no private benefit plan, must be fixed.” “We cannot afford to let an employment lottery dictate who can and who cannot access the medications that restore wellness, quality of life and full functionality that permits Canadians living with a mental illness to become productive members of Canadian society,” he adds. SOURCE Canadians for Equitable Access to Depression Medication

Buying Bread or Paying for Your Medication? Public Drug Plans Must Cover Cost of Latest Depression Medications OTTAWA, May 17, 2017 /CNW/ – Ron Campbell and Brianne Moore — on behalf of millions of other Canadians living with mental illness and depression — have a message for Minister of Health Jane Philpott following her address … Continue reading Buying Bread or Paying for Your Medication? Public Drug Plans Must Cover Cost of Latest Depression Medications OTTAWA, May 17, 2017 /CNW/ – Ron Campbell and Brianne Moore — on behalf of millions of other Canadians living with mental illness and depression — have a message for Minister of Health Jane Philpott following her address yesterday at The Economic Club of Canada. Their message is this: an effectively reformed system to review patented medications must include the many people who are currently shut out from getting the latest — and most effective — medications for their depression. Ron and Brianne are referring to Canada’s publicly funded drug plan system, which currently does not cover many of the latest innovative depression medications that Canadians need to treat their illness. Those medications are only available through private health plans. Right now, Canada’s most vulnerable, including veterans, seniors, single parents, Indigenous peoples, the unemployed and homeless people, are shut out. That’s because publicly funded drug plans don’t cover the cost of the latest innovative medicines designed to treat depression. All these Canadians, say Ron and Brianne, are part of an untold story. “It’s a travesty,” says Ron, a retired RCMP officer with both PTSD and major depressive disorder. He’s one of the lucky ones because he has private drug plan coverage. After years of tweaking and crashing, more tweaking and crashing, his specialist found the right combination of medications that make it possible for him to cope — and live. “I’m finally in the best place I’ve been in 13 years,” says the man who twice came within a hair’s breadth of ending his life, once with pistol in hand. “I don’t know what I would have done if I didn’t have private drug plan coverage.” Ron is concerned about all those others he sees who struggle to get through their day without the benefit of the medication that will work for them — or people like Brianne who sometimes forfeits the medication she needs when she can’t afford it. Brianne is only 19, but she has struggled with mental illness for virtually her entire life and has had to pay for her own medications for the last three years. Life’s hard, but things would certainly be easier if her medication was covered under the public drug plan. “You shouldn’t have to choose between buying food or the medication you need to stay mentally healthy,” she says. “Unfortunately, sometimes those are the only choices I have.” Ron and Brianne are members of the newly formed Canadians for Equitable Access to Depression Medications (CEADM). CEADM is calling on Minister Philpott to fix the system, ensuring that all Canadians living with mental illness, regardless of their income, have access to the latest medications for depression. “Minister Philpott is correct to tackle the high price of patented medications, and we are pleased that she has also touched on the important issue of access, but her plan for reform does not go far enough,” says Phil Upshall, a member of CEADM’s National Leadership Team and National Executive Director of the Mood Disorders Society of Canada. “Yes, developing a common national formulary that reflects the 21st century’s ‘patient-centered care’ philosophy is an important step in the right direction to improve affordability and accessibility. But Canada’s inequitable public drug plan system, which leaves many people out in the cold, the hardest hit being the most vulnerable in society and those with no private benefit plan, must be fixed.” “We cannot afford to let an employment lottery dictate who can and who cannot access the medications that restore wellness, quality of life and full functionality that permits Canadians living with a mental illness to become productive members of Canadian society,” he adds. SOURCE Canadians for Equitable Access to Depression Medication